0001179110-13-013834.txt : 20130904
0001179110-13-013834.hdr.sgml : 20130904
20130904190957
ACCESSION NUMBER: 0001179110-13-013834
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130830
FILED AS OF DATE: 20130904
DATE AS OF CHANGE: 20130904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOORE NICHOLAS G
CENTRAL INDEX KEY: 0001216923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 131078978
MAIL ADDRESS:
STREET 1: 495 EAST JAVA DRIVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
4
1
edgar.xml
FORM 4 -
X0306
4
2013-08-30
0
0000882095
GILEAD SCIENCES INC
GILD
0001216923
MOORE NICHOLAS G
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
0
0
0
Common Stock
2013-08-30
4
M
0
130000
20.705
A
130000
I
by Trust
Common Stock
2013-08-30
4
M
0
21720
19.63
A
151720
I
by Trust
Common Stock
2013-08-30
4
S
0
146904
60.3981
D
4816
I
by Trust
Common Stock
2013-08-30
4
S
0
4816
61.0175
D
0
I
by Trust
Non-Qualified Stock Options (right to buy)
19.63
2013-08-30
4
M
0
21720
0
D
2020-05-11
Common Stock
21720
0
I
by Trust
Non-Qualified Stock Options (right to buy)
20.705
2013-08-30
4
M
0
130000
0
D
2017-05-09
Common Stock
130000
0
I
by Trust
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
Options vest quarterly over a period of one year from the date of grant.
Options are 100% vested on the date of grant.
Sale prices reported for the transactions reported here range from $59.97 to $60.96. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $60.97 to $61.12. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
/s/ Gregg H. Alton by Power of Attorney for Nicholas G. Moore
2013-09-04